Company: RGBP
Filing Date: 2025-02-24
Form Type: 253G1
Source: 0001493152-25-008067
Chunk: 52

Company: Regen BioPharma Inc
Filing Date: 2025-02-24
Form: 253G1
Chunk 52
---
 to the audit in order to design audit procedures     
 that are appropriate in the circumstances, but not for the purpose of expressing an opinion        
 on the effectiveness of Regen Biopharma, Inc’s internal control. Accordingly, no such              
 opinion is expressed.                                                                              |
| ● | Evaluate                                                                                           
 the appropriateness of accounting policies used and the reasonableness of significant accounting   
 estimates made by management, as well as evaluate the overall presentation of the financial        
 statements.                                                                                        |
| ● | Conclude                                                                                           
 whether, in our judgment, there are conditions or events, considered in the aggregate, that        
 raise substantial doubt about Regen Biopharma, Inc’s ability to continue as a going                
 concern for a reasonable period of time.                                                           |

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

Critical Audit Matter

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

| 40 |

Audit Scope and Procedures:

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB)and U.S. Generally Accepted Accounting Principles (GAAP). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.

As part of our audit, we focused on the following key areas:

1. Balance Sheet

Assets:

Accounts Receivable:A detailed review of accounts receivable was performed. We confirm that no material misstatements exist and the receivables are appropriately stated. No allowance for doubtful accounts was deemed necessary based on management’s assessment.

Prepaid Expensesand Investment Securitieswere audited, and the company’s treatment is compliant with U.S. GAAP. Prepaid expenses are correctly amortized, and investment securities are valued appropriately at fair value.

Liabilities:

Convertible Debt:The audit confirms that the convertible debt is accurately bifurc